Nifty Pharma Prediction for Tomorrow, 16 October 2026 (Including F&O)

This nifty pharma prediction for tomorrow follows a Thursday, 15 October 2026 session in which the Nifty Pharma index rose 0.31 percent to 25,817.80, a modest rebound after Wednesday's 1.30 percent fall.

Ankit Jaiswal, Senior Research Analyst at Univest, and Kunal Singla, Associate Director at Univest, are tracking sector-specific triggers and F&O positioning ahead of the session tomorrow, which falls on Friday, 16 October 2026.

Click Here – Get Free Investment Predictions

What Thursday Told Us

• Nifty Pharma closed at 25,817.80, up 0.31 percent on 15 October 2026.
• The broader Nifty 50 rose 1.66 percent.
• India VIX fell 4.10 percent to 14.03.

Nifty Pharma Prediction for Tomorrow: Key Levels

Nifty Pharma traded between 25,599.00 and 25,950.95 on Thursday, against a previous close of 25,736.95, and settled at 25,817.80. On the downside, 25,736.95 and 25,599.00 are the first reference levels to watch if the day's move is tested. On the upside, 25,950.95 marks the nearest resistance. Univest's analysts treat these as reference points drawn from Thursday's trading range, not as targets.

Trend	Support	Resistance
Positive	25,736.95, 25,599.00	25,950.95

The table uses Thursday's high, low and previous close for Nifty Pharma.

Key Drivers for Tomorrow

• Nifty Pharma rose 0.31 percent to 25,817.80, with a high of 25,950.95 and a low of 25,599.00.
• The index recovered from a low of 25,599 but only about a quarter of Wednesday's fall.
• US generic pricing and regulatory updates are the sector's usual triggers.

Anyone following this nifty pharma prediction for tomorrow should keep the next session's opening range in view before reading too much into early moves.

Stocks and Triggers to Watch in the Nifty Pharma Space

Nifty Pharma is a defensive group that tends to lag in sharp risk-on rallies. The partial rebound shows some buying after the fall.

In the F&O segment, Univest's analysts suggest watching open-interest changes near the support and resistance levels above before drawing conclusions. India VIX fell 4.10 percent to 14.03 on Thursday, which usually supports calmer option pricing, though a jump would widen expected ranges.

Univest's analysts suggest treating this nifty pharma prediction for tomorrow as a preparation note for Friday, 16 October 2026, rather than a signal that changes overnight.

These are educational views, not buy calls, and each should be checked against your own risk plan before acting.

How Thursday's Broader Session Unfolded

The Nifty 50 closed at 22,997.35, up 1.66 percent, with a high of 23,056.40 and a low of 22,637.40. The Sensex closed at 74,315.61, up 2.11 percent, and the Bank Nifty closed at 55,810.50, up 0.89 percent. India VIX, the market's fear gauge, fell 4.10 percent to 14.03, which usually points to calmer expected swings in the near term. The Thursday rally followed a fall on Wednesday, so part of the move may be a rebound rather than a fresh uptrend. The trigger for the broad gain was not independently confirmed.

This nifty pharma prediction for tomorrow will be most useful when read alongside the support and resistance table above.

Analyst View for Tomorrow

Kunal Singla suggests that the sector can stay steady above 25,599, Thursday's low, with 26,075 the Tuesday level to reclaim.

Ankit Jaiswal flags that US pricing trends and regulatory headlines matter more than daily market direction here.

A fair reading of this nifty pharma prediction for tomorrow is that Thursday's data sets the context, while Friday's first hour decides how much of it carries forward.

Why This Is Written for Tomorrow

This nifty pharma prediction for tomorrow is written after the close on Thursday, 15 October 2026, using Thursday's closing data, for the next trading session on Friday, 16 October 2026. Treat it as a briefing to prepare for that session, not a live call that updates through the evening.

Track the Nifty Pharma Space on Univest Screeners

Readers comparing views should note that this nifty pharma prediction for tomorrow draws only on Thursday's closing numbers and the factors listed here.

Risks to This Prediction

• A rise in the rupee could trim export earnings for pharma makers.
• US regulatory action can hurt individual stocks.
• Money rotating into banks and IT could keep pharma lagging.

As with any nifty pharma prediction for tomorrow, the opening minutes of Friday's trade will confirm or challenge the levels discussed here.

The nifty pharma prediction for tomorrow also depends on India VIX, so a fresh rise in volatility would weaken the case made here.

Download the Univest iOS App or Univest Android App to get daily market recommendations and insightful research pieces.

Conclusion

The nifty pharma prediction for tomorrow leans steady into 16 October 2026, with broader Nifty 50 direction and India VIX as the key variables to track. Ankit Jaiswal and Kunal Singla will revisit this view once Friday's opening trade confirms direction.

Disclaimer: Investments in securities are subject to market risk. Read all related documents carefully before investing. The information provided here is for educational purposes only and does not constitute investment advice. Univest is a SEBI-registered investment adviser (Registration No. INH000013776). Past performance is not indicative of future returns.

Frequently Asked Questions

What is the nifty pharma prediction for tomorrow?

Ans. It is steady for 16 October 2026, after Nifty Pharma closed at 25,817.80 on Thursday, up 0.31 percent.

Why is this a prediction for tomorrow, 16 October 2026?

Ans. Because it is written after the close on Thursday, 15 October 2026, for the next regular trading session on Friday, 16 October 2026.

Why did Nifty Pharma rise modestly on Thursday?

Ans. Nifty Pharma rose 0.31 percent while the Nifty 50 rose 1.66 percent. The reason was not independently confirmed.

What are the key levels for Nifty Pharma tomorrow?

Ans. Thursday's low of 25,599.00 and the previous close of 25,736.95 are support below the price, while Thursday's high of 25,950.95 is the nearest resistance.

Is this a buy or sell call?

Ans. No. This is an educational outlook from Univest's research team, not a buy or sell call. Traders should check any view against their own risk plan before acting.